Introduction
============

Angiosarcoma is a rare malignant vascular tumor and is difficult to diagnose and treat ([@b1-ol-0-0-5968]). It may be characterized by rapidly proliferating and extensively infiltrating anaplastic cells, which are derived from blood vessels, and lining irregular blood-filled spaces ([@b2-ol-0-0-5968],[@b3-ol-0-0-5968]). Angiosarcoma is derived from mesenchymal cells and usually originates from the liver, breast, spleen, bone or heart ([@b2-ol-0-0-5968],[@b4-ol-0-0-5968]--[@b6-ol-0-0-5968]). Angiosarcoma accounts for between 1 and 2% of all sarcomas, and its overall 5-year survival rate is \<20%, owing to the high recurrence and distant metastasis rates ([@b2-ol-0-0-5968]). In addition, metastasis usually occurs in the liver, lung, bone and lymph nodes ([@b7-ol-0-0-5968]). Treatment of angiosarcoma is multifaceted and primarily consists of radiotherapy, surgery and chemotherapy ([@b8-ol-0-0-5968]).

Propranolol is a non-selective β-blocker and may inhibit the growth of angiosarcoma by affecting the proliferation and differentiation of angiosarcoma tumor cells, thus being considered a promising treatment to delay surgery ([@b9-ol-0-0-5968]--[@b11-ol-0-0-5968]). However, its underlying molecular mechanisms and pharmacodynamics of the effects on angiosarcoma remain obscure, and the potential target genes involved in the proliferation and differentiation processes of angiosarcoma tumor cells also require investigation.

Gene microarray is widely used as an effective technology to detect the gene expression in cells and tissues at different disease stages of cancer. Thus, it may aid in the identification of novel signaling pathways or molecular mechanisms associated with tumorigenesis.

In the present study, the differentially expressed genes (DEGs) in angiosarcoma tumor cells treated with propranolol compared with the control group were identified via a bioinformatics-based method. Furthermore, enenrichment analysis, protein-protein interaction (PPI) network construction and module analysis were performed. These analyses aided in the identification of essential genes associated with angiosarcoma, such as AXL receptor tyrosine kinase (AXL), coatomer subunit α, DR1-associated protein 1, ERBB receptor feedback inhibitor 1, family with sequence similarity 195 member A, expressed sequence AA467197, apoptosis-associated tyrosine kinase, ATP-binding cassette subfamily A member 7, acyl-CoA dehydrogenase family member 9 and acyl-CoA-binding domain containing 6. Thus, this may contribute to understanding the molecular mechanism underlying angiosarcoma in order to identify potential gene targets for the diagnosis and treatment of patients with angiosarcoma.

Materials and methods
=====================

### mRNA expression microarray data

The standardized mRNA expression profile GSE42534 ([@b9-ol-0-0-5968]) was downloaded from the Gene Expression Omnibus ([www.ncbi.nlm.nih.gov/geo/](www.ncbi.nlm.nih.gov/geo/)) database, including 3 samples without propranolol treatment (the control group), 3 samples with propranolol treatment for 4 h and 3 samples with propranolol treatment for 24 h.

### Identification and grouping of differentially expressed genes

The DEGs in angiosarcoma tumor cells of the propranolol treatment groups compared with the control group were obtained using the limma package of R (<http://bioconductor.org/packages/release/bioc/html/limma.html>) ([@b12-ol-0-0-5968]). They were designated DEGs-4 h and DEGs-24 h. The DEGs-24 h were divided into 2 sets. Set 1 contained those DEGs also contained in the DEGs-4 h group. Set 2 contained the remainder of the DEGs. For the sake of accuracy, all DEGs were identified according to the following criteria: P\<0.001;\|log~2~ (fold-change) \|≥1.

### Gene ontology (GO) and pathway enrichment analysis

In order to explore the potential biological processes that were altered, GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID; [david.abcc.ncifcrf.gov/](david.abcc.ncifcrf.gov/)) ([@b13-ol-0-0-5968]). The GO terms and the KEGG pathways were identified with the criterion P\<0.05.

### Construction of protein-protein interaction (PPI) networks

The two PPI networks for sets 1 and 2 were constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) ([@b14-ol-0-0-5968]) database, termed PPI 1 and PPI 2, respectively, and visualized using Cytoscape software (version 3.4.0; <http://www.cytoscape.org/>) ([@b15-ol-0-0-5968]). STRING, which manipulates the interactions between genes or proteins from multiple sources, was used to identify the interactions of DEGs. A combined score (a representation of reliability of interactions) \>0.4 was used as the threshold for the selection of interaction pairs. Modules of the two PPI networks were analyzed using the Multi Contrast Delayed Enhancement plug-in of Cytoscape ([@b16-ol-0-0-5968]). When the combined score was \>1.5, function enrichment analysis of all enrolled DEGs was performed using DAVID, and the GO terms and the KEGG pathways with P\<0.05 were identified. Topological structures of the two PPI networks were analyzed using tYNA ([tyna.gersteinlab.org/tyna](tyna.gersteinlab.org/tyna)) ([@b17-ol-0-0-5968]), and potential target genes, whereby the degree of node attributes was ≥10, were identified. Degree represents the number of direct interactions a node has with with other nodes.

Results
=======

### Identification of DEGs

A total of 543 DEGs (242 up- and 301 downregulated) and 2,025 DEGs (1,107 up- and 918 downregulated) were identified in angiosarcoma tumor cells treated with propranolol (DEGs-4 h and DEGs-24 h, respectively) compared with the control group. A total of 401 DEGs (set 1) were involved in DEGs-4 h and DEGs-24 h, including metallothionein 1, heme oxygenase 1, WW domain-binding protein 2 and sequestosome 1. Among set 1, 179 DEGs in the DEGs-4 h group were upregulated, of which 170 DEGs were upregulated and 9 DEGs (2410011G03Rik, 2810417H13Rik, ATPase inhibitory factor 1, G2 and S-phase expressed 1, LSM5 homolog U6 small nuclear RNA and mRNA degradation associated, non-SMS condensing I complex subunit H, Rp127, ubiquitin-40A ribosomal protein S27a precursor and zinc finger CCHC-type-containing 8) were downregulated in the DEGs-24 h group. Similarly, 222 DEGs of the DEGs-4 h group were downregulated, of which 196 DEGs were downregulated and 26 DEGs \[D730049H07Rik, desert hedgehog, dual-specificity phosphatase 7, endothelin 1, ETS proto-oncogene 1, general receptor for phosphoinositides, mitogen-associated protein kinase 6, midnolin, myeloid-associated differentiation marker, lysophosphatidic acid receptor 6, platelet-derived growth factor subunit A, PDZ and LIM domain (Pdlim) 1, Pdlim7, plexin A2, phosphatidic acid phosphatase type 2B, Ppmlf, regulator of G-protein signaling 16, ras homolog family member B, roundabout guidance receptor 4, sterile α motif domain-containing 4, solute carrier family 2 member 1, solute carrier family 9 isoform A3 regulatory factor 2, tissue inhibitor of metalloproteinase 3, tumor necrosis factor-α-induced protein 2, trophoblast glycoprotein and WNT1-inducible signaling pathway protein 1\] were upregulated in the DEGs-24 h group.

### Functional and pathway enrichment analysis of sets 1 and 2

The top 20 most significantly enriched GO terms of sets 1 and 2 are presented in [Table IA and B](#tI-ol-0-0-5968){ref-type="table"}, respectively. Among them, 28 terms were coincident ([Table IC](#tI-ol-0-0-5968){ref-type="table"}). The enriched KEGG pathways of sets 1 and 2 are presented in [Table IIA and B](#tII-ol-0-0-5968){ref-type="table"}, respectively.

### Construction of the PPI networks for sets 1 and 2 and analysis of modules

The PPI networks of PPI 1 and PPI 2 are presented in [Figs. 1](#f1-ol-0-0-5968){ref-type="fig"} and [2](#f2-ol-0-0-5968){ref-type="fig"}. A total of 121 nodes and 700 associated pairs were involved in PPI 1, whereas 1,324 nodes and 11,839 associated pairs were involved in PPI 2. [Fig. 3](#f3-ol-0-0-5968){ref-type="fig"} and [Table IIIA](#tIII-ol-0-0-5968){ref-type="table"} present the module information of PPI 1. [Fig. 4](#f4-ol-0-0-5968){ref-type="fig"} and [Table IIIB](#tIII-ol-0-0-5968){ref-type="table"} present the module information of PPI 2.

### Extent of enriched function and topological structure analysis of the PPI networks

There were 20 GO terms (including nucleolus, intracellular organelle lumen, membrane-enclosed lumen, ribosome biogenesis and RNA processing) and no KEGG pathways enriched in module 1 of PPI 1. The numbers of the enriched module functions of PPI 2 are presented in [Table IV](#tIV-ol-0-0-5968){ref-type="table"}. The results identified that no enriched KEGG pathways appeared in modules 1 and 9 of PPI 2. A total of 45 and 593 potential target genes were obtained according to the node degrees of PPI 1 and PPI 2, and the top 10 nodes (potential target genes) which were associated with the other nodes in the PPI networks for sets 1 and 2 are presented in [Table VA](#tV-ol-0-0-5968){ref-type="table"} and [VB](#tV-ol-0-0-5968){ref-type="table"}, respectively.

Discussion
==========

Numerous studies have demonstrated the selective cytotoxicity and relative safety of propranolol on vascular tumors, and laid the groundwork for the notable efficacy and the suppressive ability of propranolol on angiosarcoma ([@b9-ol-0-0-5968]--[@b11-ol-0-0-5968],[@b18-ol-0-0-5968]--[@b20-ol-0-0-5968]). In the present study, it was found that the number of DEGs-24 h was higher compared with the number of DEGs-4 h. In addition, nearly all of the DEGs-4 h overlapped with and were contained in the DEGs-24 h group. Furthermore, differential expression (upregulated or downregulated) of DEGs-24 h was more evident compared with DEGs-4 h. This indicated that the 401 overlapping DEGs in set 1 were important in the effects of propranolol on angiosarcoma tumor cells. Notably, 9 upregulated DEGs of the DEGs-4 h group were downregulated in the DEGs-24 h group, whereas 26 downregulated DEGs of the DEGs-4 h group were upregulated in the DEGs-24 h group. It was possible that these genes perform multiple roles in the effect of propranolol on angiosarcoma; however, this conjecture requires additional experimental verification.

The enriched GO terms of set 1 primarily contained 'angiogenesis, blood vessel morphogenesis, vasculature development', 'sterol biosynthetic process, cholesterol biosynthetic process, lipid biosynthetic process', 'lysosome, lytic vacuole, vacuole', and 'nucleolus, intracellular non-membrane-bounded organelle, regulation of cell proliferation'. It is well known that lipid metabolism may affect the development of blood vessels ([@b21-ol-0-0-5968]--[@b23-ol-0-0-5968]) and various organelles involved in various biological processes ([@b23-ol-0-0-5968],[@b24-ol-0-0-5968]). Cell proliferation is an essential process in the development of blood vessels ([@b25-ol-0-0-5968]). According to [Table IA](#tI-ol-0-0-5968){ref-type="table"}, the majority of enriched GO terms of set 1 were associated with the biological processes of blood vessels, whereas the enriched GO terms of set 2 were primarily associated with energy metabolism (including ribosome, structural constituent of ribosome), protein transfer (including ribonucleoprotein complex, ribosome, membrane-enclosed lumen) and compounds biosynthesis (including RNA processing, mRNA metabolic process and envelope). The overlapping enriched GO terms of sets 1 and 2 were primarily involved in nucleic acid metabolism, nucleotide biosynthesis and nucleic acid binding. Therefore, it was concluded that propranolol affected angiosarcoma primarily by influencing the biological processes of blood vessels in the early stage and by effecting the biological metabolism and transfer processes in the later stage. The enriched KEGG pathways of set 1 were tumor-associated biological processes, including the p53 signaling pathway and cysteine and methionine metabolism. In the later stage, the enriched KEGG pathways were more extensive, including the ribosome signaling pathway, lysosome signaling pathway, Huntington\'s disease and Parkinson\'s disease.

According to the topological structure analysis of the PPI networks, certain potential biomarkers were identified, including AXL, coatomer subunit α, DR1-associated protein 1, ERBB receptor feedback inhibitor 1, family with sequence similarity 195 member A, expressed sequence AA467197, apoptosis-associated tyrosine kinase, ATP-binding cassette subfamily A member 7, acyl-CoA dehydrogenase family member 9 and acyl-CoA-binding domain containing 6. According to [Table VA](#tV-ol-0-0-5968){ref-type="table"}, *AXL* was the most significantly meaningful gene in the early stage. *AXL* is a member of the tyrosine kinase receptor family and is associated with cell adhesion and recognition, cell proliferation, apoptosis, blood coagulation and inflammation ([@b26-ol-0-0-5968]). It performs important roles in the occurrence and development of various tumors, including the inhibition of tumor cell apoptosis, the involvement in tumor angiogenesis and cellular invasion ([@b27-ol-0-0-5968]--[@b30-ol-0-0-5968]). Following its original identification, the upregulation of *Axl* has been reported in a variety of hematopoietic tumors, including leukemia and melanoma ([@b31-ol-0-0-5968]--[@b35-ol-0-0-5968]). Furthermore, previous studies have demonstrated that *Axl* may also perform a role in a number of chemotherapy-resistant cancers ([@b36-ol-0-0-5968],[@b37-ol-0-0-5968]). In the present study, it was proposed that *Axl* may be a potential target in the early stage of angiosarcoma treated with propranolol. This discovery may indicate an important direction for future studies. Similarly, *AA467197* may be a potential biomarker in the late stage of angiosarcoma treated with propranolol. It is a key point of the effects of propranolol on angiosarcoma to identify and develop small-molecule drugs with the potential to selectively inhibit *Axl* and *AA467197* expression and their signaling pathways.
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###### 

Significantly enriched and coincident GO terms in sets 1 and 2.

  A, Top 20 most significantly enriched GO terms in set 1                                                                
  --------------------------------------------------------- ---------------------------------------------- ------------- --------------------------------------------------------------------------
  GO:0005730                                                Nucleolus                                      23            0.000000006
  GO:0016126                                                Sterol biosynthetic process                      8           0.000000580
  GO:0031974                                                Membrane-enclosed lumen                        43            0.000000604
  GO:0001525                                                Angiogenesis                                   12            0.000017900
  GO:0070013                                                Intracellular organelle lumen                  38            0.000025500
  GO:0043233                                                Organelle lumen                                38            0.000027000
  GO:0006694                                                Steroid biosynthetic process                     9           0.000027800
  GO:0006695                                                Cholesterol biosynthetic process                 6           0.000037100
  GO:0048514                                                Blood vessel morphogenesis                     14            0.000037200
  GO:0016125                                                Sterol metabolic process                         9           0.000050400
  GO:0001568                                                Blood vessel development                       15            0.000081700
  GO:0031981                                                Nuclear lumen                                  31            0.000082000
  GO:0001944                                                Vasculature development                        15            0.000106000
  GO:0005773                                                Vacuole                                        13            0.000118000
  GO:0008610                                                Lipid biosynthetic process                     16            0.000120000
  GO:0005764                                                Lysosome                                       12            0.000148000
  GO:0000323                                                Lytic vacuole                                  12            0.000156000
  GO:0043232                                                Intracellular non-membrane-bounded organelle   51            0.000304000
  GO:0043228                                                Non-membrane-bounded organelle                 51            0.000304000
  GO:0042127                                                Regulation of cell proliferation               22            0.000387000
                                                                                                                         
  B, Top 20 most significantly enriched GO terms in set 2                                                                
                                                                                                                         
  GO ID                                                     GO name                                        Gene number   P-value
                                                                                                                         
  GO:0030529                                                Ribonucleoprotein complex                      100           0.000000000000
  GO:0005739                                                Mitochondrion                                  178           0.000000000000
  GO:0005840                                                Ribosome                                         52          0.000000000000
  GO:0044429                                                Mitochondrial part                               84          0.000000000001
  GO:0003735                                                Structural constituent of ribosome               39          0.000000000002
  GO:0043233                                                Organelle lumen                                142           0.000000000003
  GO:0031974                                                Membrane-enclosed lumen                        145           0.000000000005
  GO:0070013                                                Intracellular organelle lumen                  141           0.000000000006
  GO:0043228                                                Non-membrane-bounded organelle                 208           0.000000000014
  GO:0043232                                                Intracellular non-membrane-bounded organelle   208           0.000000000014
  GO:0006412                                                Translation                                      58          0.000000000047
  GO:0031090                                                Organelle membrane                             108           0.000000000050
  GO:0005681                                                Spliceosome                                      33          0.000000000056
  GO:0006396                                                RNA processing                                   70          0.000000000140
  GO:0008380                                                RNA splicing                                     42          0.000000000438
  GO:0031967                                                Organelle envelope                               79          0.000000000456
  GO:0031975                                                Envelope                                         79          0.000000000543
  GO:0019866                                                Organelle inner membrane                         54          0.000000001140
  GO:0006397                                                mRNA processing                                  48          0.000000002120
  GO:0016071                                                mRNA metabolic process                           51          0.000000010600
                                                                                                                         
  C, Coincident enriched GO terms in sets 1 and 2                                                                        
                                                                                                                         
  GO ID                                                     GO name                                        GO ID         GO name
                                                                                                                         
  GO:0000166                                                Nucleotide binding                             GO:0031981    Nuclear lumen
  GO:0005730                                                Nucleolus                                      GO:0032553    Ribonucleotide binding
  GO:0005773                                                Vacuole                                        GO:0032555    Purine ribonucleotide binding
  GO:0005783                                                Endoplasmic reticulum                          GO:0034404    Nucleobase, nucleoside and nucleotide biosynthetic process
  GO:0005829                                                Cytosol                                        GO:0034654    Nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process
  GO:0006334                                                Nucleosome assembly                            GO:0034728    Nucleosome organization
  GO:0006364                                                rRNA processing                                GO:0042254    Ribosome biogenesis
  GO:0006396                                                RNA processing                                 GO:0043228    Non-membrane-bounded organelle
  GO:0009165                                                Nucleotide biosynthetic process                GO:0043232    Intracellular non-membrane-bounded organelle
  GO:0016072                                                rRNA metabolic process                         GO:0043233    Organelle lumen
  GO:0017076                                                Purine nucleotide binding                      GO:0044271    Nitrogen compound biosynthetic process
  GO:0022613                                                Ribonucleoprotein complex biogenesis           GO:0046907    Intracellular transport
  GO:0030529                                                Ribonucleoprotein complex                      GO:0051726    Regulation of cell cycle
  GO:0031974                                                Membrane-enclosed lumen                        GO:0070013    Intracellular organelle lumen

GO, gene ontology; set 1, coincident differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 4 h and treated with propranolol for 4 h compared with treated without propranolol; set 2, differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 24 h compared with treated without propranolol, but not in angiosarcoma tumor cells treated with propranolol for 4 h compared with treated without propranolol.

###### 

Enriched KEGG pathways in sets 1 and 2.

  A, Enriched KEGG pathways in set 1                               
  -------------------------------------------------------- ------- ----------
  mmu04115: p53 signaling pathway                            9     0.000105
  mmu00100: Steroid biosynthesis                             5     0.000398
  mmu00900: Terpenoid backbone biosynthesis                  4     0.003012
  mmu04142: Lysosome                                         9     0.004013
  mmu00600: Sphingolipid metabolism                          5     0.012340
  mmu00240: Pyrimidine metabolism                            7     0.017197
  mmu00270: Cysteine and methionine metabolism               4     0.033547
  mmu00650: Butanoate metabolism                             4     0.044913
  mmu05214: Glioma                                           5     0.048883
                                                                   
  B, Enriched KEGG pathways in set 2                               
                                                                   
  Term                                                     Count   P-value
                                                                   
  mmu03040: Spliceosome                                    37      0.000000
  mmu00190: Oxidative phosphorylation                      31      0.000001
  mmu03010: Ribosome                                       22      0.000026
  mmu04142: Lysosome                                       24      0.000291
  mmu05211: Renal cell carcinoma                           17      0.000350
  mmu00480: Glutathione metabolism                         13      0.001727
  mmu05016: Huntington\'s disease                          28      0.006229
  mmu05012: Parkinson\'s disease                           22      0.007000
  mmu05222: Small cell lung cancer                         16      0.007770
  mmu03030: DNA replication                                  9     0.010537
  mmu04666: Fc gamma R-mediated phagocytosis               17      0.012796
  mmu04114: Oocyte meiosis                                 19      0.013122
  mmu03018: RNA degradation                                12      0.016095
  mmu04110: Cell cycle                                     20      0.018766
  mmu05200: Pathways in cancer                             41      0.020303
  mmu04662: B cell receptor signaling pathway              14      0.024365
  mmu05212: Pancreatic cancer                              13      0.024948
  mmu00600: Sphingolipid metabolism                          9     0.030444
  mmu00980: Metabolism of xenobiotics by cytochrome P450   12      0.031062
  mmu00330: Arginine and proline metabolism                10      0.043757
  mmu00860: Porphyrin and chlorophyll metabolism             7     0.046693
  mmu00511: Other glycan degradation                         5     0.048603
  mmu04062: Chemokine signaling pathway                    24      0.056122
  mmu05010: Alzheimer\'s disease                           24      0.056122
  mmu05215: Prostate cancer                                14      0.056323
  mmu04620: Toll-like receptor signaling pathway           15      0.056726
  mmu03410: Base excision repair                             8     0.061961
  mmu00230: Purine metabolism                              21      0.066837
  mmu00982: Drug metabolism                                12      0.068874
  mmu04920: Adipocytokine signaling pathway                11      0.073182
  mmu04810: Regulation of actin cytoskeleton               27      0.075019

KEGG, Kyoto Encyclopedia of Genes and Genomes; set 1, coincident differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 4 h and treated with propranolol for 4 h compared with treated without propranolol; set 2, differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 24 h compared with treated without propranolol, but not in angiosarcoma tumor cells treated with propranolol for 4 h compared with treated without propranolol; DEGs, differentially expressed genes.

###### 

Module information of the protein-protein interaction networks for sets 1 and 2.

  A, Module information of the protein-protein interaction network of set 1                         
  --------------------------------------------------------------------------- ------- ------------- -------------
    1                                                                         10.4    25            260
    2                                                                           1.5     4               6
    3                                                                           1.5     7             10
                                                                                                    
  B, Module information of the protein-protein interaction network of set 2                         
                                                                                                    
  Module ID                                                                   Score   Gene number   Edge number
                                                                                                    
    1                                                                         17.1    70            1195
    2                                                                           9.4   41              387
    3                                                                           6.8   16              109
    4                                                                           6.4   70              446
    5                                                                           5.2   56              292
    6                                                                           3.6   74              267
    7                                                                           2.9   39              113
    8                                                                           2.9     7               20
    9                                                                           2.5   40                99
  10                                                                            1.7   24                41

Set 1, coincident differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 4 h and treated with propranolol for 4 h compared with treated without propranolol; set 2, differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 24 h compared with treated without propranolol, but not in angiosarcoma tumor cells treated with propranolol for 4 h compared with treated without propranolol.

###### 

Enriched function numbers of modules of the protein-protein interaction network of set 2.

  Modules     Enriched GO term numbers   Enriched KEGG pathway number
  ----------- -------------------------- ------------------------------
  Module 1        0                        0
  Module 2      47                         1
  Module 3      10                         1
  Module 4    122                          6
  Module 5      62                         5
  Module 6      90                       11
  Module 7    105                        15
  Module 8      12                         1
  Module 9    154                          0
  Module 10     22                         6

Set 2, differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 24 h compared with treated without propranolol, but not in angiosarcoma tumor cells treated with propranolol for 4 h compared with treated without propranolol; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.

###### 

Top 10 nodes most significantly associated with other nodes in the protein-protein interaction network of sets 1 and 2.

  A, Top 10 nodes most significantly associated with other nodes in the protein-protein interaction network of set 1                                                    
  -------------------------------------------------------------------------------------------------------------------- -------- ------------------------ -------------- ------------------------
  AXL                                                                                                                  45       0                        6              0
  COPA                                                                                                                 44       0                        7              0
  DRAP1                                                                                                                44       0                        2              0
  ERRFI1                                                                                                               41       0                        2              0
  FAM195A                                                                                                              38       0                        8              0
  FAM98A                                                                                                               36       0                        8              0
  FASTKD5                                                                                                              36       0                        8              0
  FEZ2                                                                                                                 33       0                        2              0
  FST                                                                                                                  33       0                        6              0
  GADD45G                                                                                                              33       0                        7              0
                                                                                                                                                                        
  B, Top 10 nodes most significantly associated with other nodes in the protein-protein interaction network of set 2                                                    
                                                                                                                                                                        
  Gene symbol                                                                                                          Degree   Clustering coefficient   Eccentricity   Betweenness centrality
                                                                                                                                                                        
  AA467197                                                                                                             184      0                        2              0
  AATK                                                                                                                 120      0                        8              0
  ABCA7                                                                                                                120      0                        7              0
  ACAD9                                                                                                                116      0                        2              0
  ACBD6                                                                                                                113      0                        8              0
  ACSL3                                                                                                                111      0                        9              0
  AFG3L1                                                                                                               109      0                        7              0
  AGAP1                                                                                                                109      0                        8              0
  AHNAK                                                                                                                106      0                        9              0
  ANGEL2                                                                                                               106      0                        7              0

Set 1, coincident differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 4 h and treated with propranolol for 4 h compared with treated without propranolol; set 2, differentially expressed genes in angiosarcoma tumor cells treated with propranolol for 24 h compared with treated without propranolol, but not in angiosarcoma tumor cells treated with propranolol for 4 h compared with treated without propranolol.
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